Clinical Trials Directory

Trials / Sponsors / Aurigene Discovery Technologies Limited

Aurigene Discovery Technologies Limited

Industry · 11 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
TerminatedA Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103
HER 2 Positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Phase 1 / Phase 22025-03-22
RecruitingStudy Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lym
Relapsed Advanced Lymphomas
Phase 12025-01-15
TerminatedA Study of AUR104 in Patients With Relapsed/Refractory Lymphoid Malignancies (VIJAY-1)
Select Relapsed/Refractory Lymphoid Malignancies
Phase 12024-12-12
TerminatedA Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Col
Ovarian Cancer, Colorectal Cancer, Renal Cancer
Phase 22024-11-09
RecruitingA Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)
Relapsed Advanced Lymphomas
Phase 12023-10-19
RecruitingA Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1
Relapsed Malignant Solid Neoplasm
Phase 12023-09-05
TerminatedA Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies
Relapse, Advanced Malignant Neoplasm, Non Small Cell Lung Cancer
Phase 12023-08-26
TerminatedFirst in Human, Dose Escalation, Dose Expansion Study of AUR105
Solid Tumor, Adult, Non-hodgkin Lymphoma, Hodgkin Lymphoma
Phase 12022-11-30
TerminatedA First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics
Solid Tumor, Adult, Acute Myeloid Leukemia, Myelodysplastic Syndromes
Phase 12022-09-16
CompletedA Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)
Plaque Psoriasis
Phase 22021-05-04
CompletedA Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis
Chronic Plaque-type Psoriasis
Phase 22020-01-21